ISSN: 0007-9235

CA - A Cancer Journal for Clinicians Q1 Unclaimed

Wiley-Blackwell United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

CA: A Cancer Journal for Clinicians is a peer-reviewed journal published for the American Cancer Society by John Wiley & Sons, Inc. CA publishes comprehensive review articles of a multidisciplinary nature, which take into account the journal’s diverse readership of primary care physicians; medical, surgical, and radiation oncologists; nurses; and other health care and public health professionals. Articles published in CA provide up-to-date information on all aspects of cancer prevention, early detection, treatment of all forms, palliation, advocacy, quality of life, and more. It has an SJR impact factor of 86,091.

CA - A Cancer Journal for Clinicians focuses its scope in these topics and keywords: diagnosis, cancer, management, statistics, nonmelanoma, neurotoxicity, patientscancer, peripheral, pharmacogenetics, pharmacogenomics, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Hematology (Q1) Oncology (Q1)

Price

2500 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

86,091

SJR Impact factor

198

H Index

44

Total Docs (Last Year)

118

Total Docs (3 years)

4268

Total Refs

30318

Total Cites (3 years)

85

Citable Docs (3 years)

299.99

Cites/Doc (2 years)

97

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Hematology and Oncology Q1
Blood Q1
The Lancet Haematology Q1
Blood Cancer Journal Q1
Leukemia Q1

Compare this journals

Aims and Scope

Best articles by citations

The Mammographic Screening Trials: Commentary on the Recent Work by Olsen and Gotzsche

Viewing the: Journal of the national cancer institute

Prostate cancer

Reviewer Acknowledgment 2007

Reviewer Acknowledgment 2011

Editorial: The environmental time bomb ...that never went off

Reviewer acknowledgment 2014

Daily aspirin may reduce mortality from prostate cancer with risk of high recurrence

Few physicians prescribe 5-alpha reductase inhibitors for prostate cancer prevention

Introdiction to "evaluation of periodic breast cancer screening with mammography mathodology and early obstrvation" by shapiro, atrax, and vent

Enhancing global access to cancer medicines

Feedback

SHOW MORE ARTICLES

Commentary on "European Consensus Statement on Lung Cancer"

Increased radiation intensity found to be safe for the treatment of prostate cancer

Estrogens and increased endometrial cancer: Fact or artifact?

Consensus statement from the American Cancer Society Workshop on neuroblastoma screening: Do benifit from mass screening for neuroblastoma?

Patients with nonovarian peritoneal carcinomatosis achieve long-term survival

Acupressure and Acupuncture for Side Effects of Radiotherapy

The Current Outbreak of Kaposi's Sarcoma and Opportunistic Infections

Elimination of cancer disparities via organizational transformation and community-driven approaches

American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer

American Cancer Society guidelines for the early detection of breast cancer: update 1997

American Cancer Society guidelines on screening for breast cancer: An overview

The impact of breast cancer on sexuality, body image, and intimate relationships